2021

• Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye; Langer, Seppo Wang; Schytte, Tine; Nyman, Jan; Risum, Signe; Tsakonas, Georgios; Engleson, Jens; Halvorsen, Tarje Onsøien. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology. vol. 22 (3).
• Grønberg, Bjørn Henning; Langer, Seppo W.; Nyman, Jan; Halvorsen, Tarje Onsøien. (2021) Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply. The Lancet Oncology. vol. 22 (6).
• Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning. (2021) Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer Treatment and Research Communications. vol. 29.
• Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien; Ottestad, Anine Larsen; Lund-Iversen, Marius; Brustugun, Odd; Nymo, Dagny Førde; Paulsen, Erna-Elise; Donnem, Tom; Andersen, Sigve; Grønberg, Bjørn Henning; Richardsen, Elin. (2021) The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers. vol. 13 (17).
• Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Dale, Vibeke Grotnes; Richardsen, Elin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2021) Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy. The journal of pathology. Clinical research.

2020

• Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje; Fløtten, Øystein; Helbekkmo, Nina; Hornslien, Kjersti; Madebo, Tesfaye; Fluge, Sverre; Grønberg, Bjørn Henning. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica.
• Halvorsen, Tarje Onsøien; Valan, Christine Damgaard; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle. vol. 11 (5).
• Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2020) Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Research. vol. 40 (11).
• Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports.

2019

• Grønberg, Bjørn Henning; Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Sjøblom, Bjørg; Jordhøy, Marit Slaaen. (2019) Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle.
• Stokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier; Killingberg, Kristin Toftaker; Fluge, Sverre; HORNSLIEN, KJERSTI; Grønberg, Bjørn Henning. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC ; Barcelona. 2019-09-07 - 2019-09-10.
• Wahl, Sissel Gyrid Freim; Dai, Hong Yan; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Richardsen, Elin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2019) Prognostic value of mutated KRAS in circulating tumor DNA prior to therapy in patients with lung cancer. World Conference on Lung Cancer 2019 . IASLC; Barcelona. 2019-09-07 - 2019-09-10.

2018

• Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2018) Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC). Best Practice Onkologi/Hematologi.
• Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.; Brustugun, Odd Terje; Fløtten, Øystein; Levin, Nina; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning. (2018) Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research. vol. 38 (2).

2017

• Krogstad, Hilde; Brunelli, Cinzia; Sand, Kari; Andersen, Eivind; Garresori, Herish; Halvorsen, Tarje Onsøien; Haukland, Ellinor Christin; Jordal, Frode; Kaasa, Stein; Loge, Jon Håvard; Løhre, Erik Torbjørn; Raj, Sunil Xavier; Hjermstad, Marianne Jensen. (2017) Development of EirV3: A computer-based tool for patient-reported outcome measures in cancer. JCO Clinical Cancer Informatics. vol. 2017 (1).